Journal of the Korean Continence Society最新文献_第2页

Postpartum Emphysematous Cystitis after Casarean Section 剖宫产术后产后肺气肿性膀胱炎

Journal of the Korean Continence Society Pub Date : 2009-12-31 DOI: 10.5213/JKCS.2009.13.2.159

H. Park, Won Seok Sim, I. Choi, J. Chang, K. Kim, Han Jung, S. Yoon, Min Sung Lee, Tae Beom Kim

引用次数: 0

The Factors Affecting the Compliance of Additional Anticholinergic Medication in the Patients with Benign Prostatic Hyperplasia. 影响良性前列腺增生患者额外抗胆碱能药物依从性的因素。

Journal of the Korean Continence Society Pub Date : 2009-06-30 DOI: 10.5213/JKCS.2009.13.1.45

Sang Hoon Kim, K. Jung, S. Cho, Hyun-woo Kim

引用次数: 0

The Effect of Tolterodine and Oxybutyninin on Nocturia in Patients with Benign Prostatic Hyperplasia. 托特罗定与奥昔布宁对良性前列腺增生患者夜尿症的影响。

Journal of the Korean Continence Society Pub Date : 2009-06-30 DOI: 10.5213/JKCS.2009.13.1.23

Jungsoo Gim, Y. Seo, K. Lee, Ki Ho Kim

{"title":"The Effect of Tolterodine and Oxybutyninin on Nocturia in Patients with Benign Prostatic Hyperplasia.","authors":"Jungsoo Gim, Y. Seo, K. Lee, Ki Ho Kim","doi":"10.5213/JKCS.2009.13.1.23","DOIUrl":"https://doi.org/10.5213/JKCS.2009.13.1.23","url":null,"abstract":"Purpose: Nocturia has been one of the most bothersome symptoms in benign prostatic hyperplasia (BPH) patients. Therefore, the authors evaluated the effect of tolterodine and oxybutyninin on nocturia in BPH patients. Materials and Methods: From September 2006 to March 2007, 82 patients who presented over than 2 in nocturnal bladder capacity index (NCBI) in spite of having alpha blockers for 6 months were enrolled. Group I (n=38) took alpha blocker with tolterodine, group II (n=44) took alpha blocker with oxybutynin. The number of their nocturia episodes was separately evaluated by the time before and after the medication. The complications were assessed using a questionnaire. Results: The number of nocturia episodes decreased by at least 1 in 68.4% (26/38), 84.1% (37/44) of patients in group I, II, respectively, and decreased by 2 or more, 1 and were unchanged or increased were 36.8, 31.6, 31.6% in group I patients and 45.5, 38.6, 15.9% in group II patients, respectively. In baseline nocturia ≥6 group, the nocturia decreased by 1 or more in 66.7%, 77.8% in group I, II, respectively. Adverse events, including dry mouth, dizziness, headache, etc, occurred in 21.1% (8/38) in group I and 27.3% (12/44) in group II patients. The complications between two groups showed no significant differences. Conclusions: Alpha blockers with tolterodine or oxybutynin can be effectively combined as a treatment option for patients with BPH complaining of unresolved nocturia. (J Korean Continence Soc 2009;13: 23-29)","PeriodicalId":231333,"journal":{"name":"Journal of the Korean Continence Society","volume":"107 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2009-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"127584902","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Psychometric Properties of the Korean Version of the Incontinence Quality of Life Instrument in Women with Stress Urinary Incontiennce 韩版尿失禁生活质量量表在女性压力性尿失禁中的心理测量特性

Journal of the Korean Continence Society Pub Date : 2009-06-30 DOI: 10.5213/JKCS.2009.13.1.51

Seung-June Oh, H. Son, S. Kim

引用次数: 2

Journal of the Korean Continence Society Pub Date : 2009-06-30 DOI: 10.5213/jkcs.2009.13.1.37

H. Chung, J. Kim, Sun Ouck Kim, Hee Sun Kim, D. Kwon, Kwangsung Park, S. Ryu

引用次数: 3

Muscarinic Receptors Distributed in the Lower Urinary Tract 毒蕈碱受体分布在下尿道

Journal of the Korean Continence Society Pub Date : 2009-06-30 DOI: 10.5213/JKCS.2009.13.1.1

D. Kim

{"title":"Muscarinic Receptors Distributed in the Lower Urinary Tract","authors":"D. Kim","doi":"10.5213/JKCS.2009.13.1.1","DOIUrl":"https://doi.org/10.5213/JKCS.2009.13.1.1","url":null,"abstract":"Acetylcholine (Ach) acting on the muscarinic receptors is the major stimulus for the detrusor inducing contraction if the bladder is distended and the bladder volume is at the threshold. There are 5 types muscarinic receptor subtypes cloned (M1-M5). Among them, the M2 subtype distributed dominantly in amount in the detrusor and its role seems to be primarily by blocking stimuli from cAMP-coupled receptors that induce relaxation. In contrast, through M3 receptors on the detrusor the strong contractile stimulus evoked even if its distribution in secondarily common. The excitatory M1 and inhibitory M2 and M4 subtypes are also expresswed prejunctionally. Like detrusor, urothelium also expressed all subtypes of muscarinic receptors, and on stimulation it releases factors affecting bladder afferents and smooth muscle. During inflammation, the expression of muscarinic M5 receptors is increased, particularly in the urothelium, together with a cholinergic-induced production of nitric oxide in the mucosa. This review will be discussed expression and functional effects of muscarinic receptors in the lower urinary tract. Clinical aspects of the different muscarinic receptors and roles in the pathologic conditions included in this discussions. (J Korean","PeriodicalId":231333,"journal":{"name":"Journal of the Korean Continence Society","volume":"57 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2009-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"129015570","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Clinical Effects of Cycloxygenase-2 Inhibitor on Nocturia. 环氧化酶-2抑制剂治疗夜尿症的临床疗效。

Journal of the Korean Continence Society Pub Date : 2009-06-30 DOI: 10.5213/JKCS.2009.13.1.67

H. Yoon, J. Yoo, K. Chun, H. Yoon

{"title":"Clinical Effects of Cycloxygenase-2 Inhibitor on Nocturia.","authors":"H. Yoon, J. Yoo, K. Chun, H. Yoon","doi":"10.5213/JKCS.2009.13.1.67","DOIUrl":"https://doi.org/10.5213/JKCS.2009.13.1.67","url":null,"abstract":"Purpose: This study aimed to examine the effects of cyclooxgenase-2 inhibitors on patients with nocturia, whose symptoms persisted after the use of first-line drug therapy, such as alpha blockers and/or anticholinergics. Materials and Methods: Thirty-three patients whose symptoms persisted after more than three months of first-line drug therapy were chosen to receive additional COX-2 inhibitors or antidiuretic hormones orally. Seven patients (group 1) were given 80mg of zaltoprofen at night, while 15 (group 2) were given 100mg of nimesulide at night. Desmopressin acetate (0.2mg) was administered at night to 11 patients (group 3) as a control group. Median follow up was 35 days (range, 28∼90 days). Results: In 25 patients (75.8%), the severity of nocturia was reduced. The median decline of nocturia in the COX-2 inhibitor groups (groups 1 and 2) was once, and it was statistically significant (p<0.001), while the median decline in each of these groups was twice (p=0.026) and once (p=0.002), respectively. The reduction of nocturia in the control group was once (p=0.011). The differences in reduction between the COX-2 inhibitor group and the control group were not statistically significant (p=0.418). Conclusions: The effects of the COX-2 inhibitors were not significantly different from those of desmopressin. Combination therapy with COX-2 inhibitors can effectively reduce nocturia in patients with refractory nocturia, following first-line drug therapy. (J Korean Continence Soc 2009;13:67-72)","PeriodicalId":231333,"journal":{"name":"Journal of the Korean Continence Society","volume":"64 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2009-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"131542260","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

The Change of Cognitive Function after Administration of Tolterodine in Brain Disease Patients with Overactive Bladder 脑疾病伴膀胱过动症患者服用托特罗定后认知功能的改变

Journal of the Korean Continence Society Pub Date : 2008-12-31 DOI: 10.5213/JKCS.2008.12.2.133

Tae Hyo Kim, Min-Jung Park, W. Cho

{"title":"The Change of Cognitive Function after Administration of Tolterodine in Brain Disease Patients with Overactive Bladder","authors":"Tae Hyo Kim, Min-Jung Park, W. Cho","doi":"10.5213/JKCS.2008.12.2.133","DOIUrl":"https://doi.org/10.5213/JKCS.2008.12.2.133","url":null,"abstract":"Puropose: It is known that anticholinergics induces cognitive dysfunction and may aggravate the state of it. Tolterodine tartrate (detrusitolR) is a widely known selective anticholinergics to bladder, which does not cause a cognitive dysfunction. This study was designed to analyze the change of cognitive function of brain disease patients, whom are taking anticholinesterase inhibitor with tolterodine for overactive bladder (OAB). Material and methods: From January 2001 to December 2004, with the patients whom have been followed for the brain disease in the department of neurology, we have analyzed 79 patients with tolterodine administered for OAB. We used K-MMSE (Korea minimental status examination) and SNSB (seoul neuropsychological screening battery) to analyze the state of cognition. Mean age of patients was 67.3±4.5 (yrs), mean administration period was 4.7±9.5 (mon). Results: 7 patients made complaints for the decline of memory, 2 of them with Parkinsonism and 2 with cerebral infarction, 1 with progressive supranuclear palsy and, 2 dementia with lewy body (DLB). Patients with DLB was excluded in this study because the disease had fluctuation of cognitive function. Conclusions: The result of these studies demonstrates tolterodine tartrate caused the decline of cognitive function in only a few patients with brain disease. We concluded that prospective studies are needed to change the cognitive functions of the brain disease patients with OAB after administration of tolterodine tartrate. (J Korean Continence Soc 2008;12:133-8)","PeriodicalId":231333,"journal":{"name":"Journal of the Korean Continence Society","volume":"24 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2008-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130192274","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Bladder Outlet Obstruction in the Female Overactive Bladder: Correct Diagnostic Criteria for Bladder Outlet Obstruction? 女性膀胱过度活动膀胱出口梗阻:膀胱出口梗阻的正确诊断标准?

Journal of the Korean Continence Society Pub Date : 2008-12-31 DOI: 10.5213/JKCS.2008.12.2.145

S. Cho, S. Kim, Joon Chul Kim

{"title":"Bladder Outlet Obstruction in the Female Overactive Bladder: Correct Diagnostic Criteria for Bladder Outlet Obstruction?","authors":"S. Cho, S. Kim, Joon Chul Kim","doi":"10.5213/JKCS.2008.12.2.145","DOIUrl":"https://doi.org/10.5213/JKCS.2008.12.2.145","url":null,"abstract":"Puropose: We analyzed retrospectively the result of urodynamic studies of the female patients with overactive bladder to reveal the incidence of accompanying bladder outlet obstruction and compared the urodynamic charateristics according to the diagnostic criteria for bladder outlet obstruction to help make the appropriate diagnosis. Material and methods: A total of 230 women who underwent urodynamic studies for evaluation of overactive bladder were retrospectively reviewed. The patients were classified as having obstruction based on two criteria, including one pressure flow cutoff point criteria (free Qmax < 12ml/ sec and pdetQmax ≧ 20cmH2O) (group I) and moderate or severe obstruction by the Blaivas- Groutz nomogram (group II). Urodynamic characteristics of the patients in Group 1 and 2 were compared with those of 42 patients having only overactive bladder without any voiding symptom (OAB group). Results: Of the patients 31 (13.5%) were in group I, 42 (18.3%) in group II. Qmax of group I was the lowest among 3 groups. Detrusor pressure at maximum measurable flow and maximum detrusor pressure during voiding in group 1 and II were significantly higher than in OAB group. Detrusor overactivity was more observed in group I and II, and there was no signigicant difference in the presence of voiding symptoms between group I and II. Only 9 patients (4%) had obstruction by both of criteria. Conclusions: Considering the high incidence of bladder outlet obstruction in the patients of overactive bladder and non-specificity of the symptoms by bladder outlet obstruction, thorough urodynamic study may be helpful in detection and treatment of bladder outlet obstruction of the overactive bladder patients. The further study for the criteria of female bladder outlet obstruction should be necessary to make its accurate diagnosis. (J Korean Continence Soc 2008;12:145-9)","PeriodicalId":231333,"journal":{"name":"Journal of the Korean Continence Society","volume":"2013 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2008-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128016396","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Diagnosis and Management of Interstitial Cystitis/ Painful Bladder Syndrome. 间质性膀胱炎/膀胱疼痛综合征的诊断和治疗。

Journal of the Korean Continence Society Pub Date : 2008-12-31 DOI: 10.5213/JKCS.2008.12.2.99

Young H. Kim

{"title":"Diagnosis and Management of Interstitial Cystitis/ Painful Bladder Syndrome.","authors":"Young H. Kim","doi":"10.5213/JKCS.2008.12.2.99","DOIUrl":"https://doi.org/10.5213/JKCS.2008.12.2.99","url":null,"abstract":"Much has changed in our understanding of the interstitial cystitis/painful bladder syndrome (IC/PBS) over time. The International Continence Society (ICS) prefers the term Painful Bladder Syndrome (PBS) defined as \"the complaint of suprapubic pain related to bladder filling, accompanied by other symptoms such as increased daytime and night-time frequency, in the absence of proven urinary infection or other obvious pathology\". Interstitial cystitis is a clinical diagnosis primarily based on symptoms of urgency/frequency and pain in the bladder and or pelvis. The pathogenesis of IC is still not completely understood, but it is likely multifactorial. The major etiologic theories include abnormality of the bladder urothelium, bladder mast cell activation, bladder inflammation, and altered bladder innervation. The sensitivity and specificity of urinary markers and the potassium sensitivity test have not been prospectively studied. Antiproliferative factor and Tamm-Horsfall protein are novel tests that may prove to be worthwhile pending future studies. Management includes patient education, dietary and lifestyle counseling, oral therapy, intravesical therapy, and surgery. Recently, the European Society for the Study of Interstitial Cystitis (ESSIC) proposed a new nomenclature and classification system. This article discusses recent data and outlines current concepts of IC/PBS. (J Korean Continence Soc 2008;12:99-113)","PeriodicalId":231333,"journal":{"name":"Journal of the Korean Continence Society","volume":"39 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2008-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133562420","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 6